Achmea Investment Management B.V. Sells 10,680 Shares of The Clorox Company (NYSE:CLX)

Achmea Investment Management B.V. lessened its stake in The Clorox Company (NYSE:CLX - Free Report) by 69.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,624 shares of the company's stock after selling 10,680 shares during the quarter. Achmea Investment Management B.V.'s holdings in Clorox were worth $751,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Clorox by 2.0% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 307,649 shares of the company's stock worth $50,119,000 after purchasing an additional 6,008 shares in the last quarter. Empower Advisory Group LLC lifted its holdings in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company's stock worth $297,000 after buying an additional 78 shares in the last quarter. Oppenheimer & Co. Inc. boosted its position in shares of Clorox by 1.6% in the third quarter. Oppenheimer & Co. Inc. now owns 17,310 shares of the company's stock valued at $2,820,000 after acquiring an additional 268 shares during the period. Huntington National Bank grew its stake in Clorox by 4.2% during the third quarter. Huntington National Bank now owns 13,786 shares of the company's stock valued at $2,246,000 after acquiring an additional 559 shares in the last quarter. Finally, OneDigital Investment Advisors LLC bought a new stake in Clorox during the 3rd quarter worth approximately $207,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Trading Up 0.3 %

Shares of CLX stock traded up $0.45 during trading hours on Wednesday, reaching $145.33. The company's stock had a trading volume of 1,105,428 shares, compared to its average volume of 1,215,082. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The stock has a market capitalization of $17.90 billion, a P/E ratio of 39.71, a P/E/G ratio of 2.62 and a beta of 0.45. The firm's fifty day simple moving average is $153.71 and its 200 day simple moving average is $160.08.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business posted $2.16 earnings per share. Equities research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.36%. Clorox's dividend payout ratio is presently 133.33%.

Analyst Ratings Changes

CLX has been the subject of a number of recent analyst reports. DA Davidson reduced their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company boosted their price objective on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.